Is hydroxyurea leukemogenic in children with sickle cell disease?

Free article

Comment

M de Montalembert et al. Blood. 2001.

Free article

. 2001 Nov 1;98(9):2878-9.

doi: 10.1182/blood.v98.9.2878.

No abstract available

Comment in

A patient on hydroxyurea for sickle cell disease who developed an opportunistic infection.
Venigalla P, Motwani B, Allen S, Agarwal M, Alva M, Westerman M, Feldman L. Venigalla P, et al. Blood. 2002 Jul 1;100(1):363. doi: 10.1182/blood-2002-03-0754. Blood. 2002. PMID: 12096715 No abstract available.

Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial.
Ferster A, Vermylen C, Cornu G, Buyse M, Corazza F, Devalck C, Fondu P, Toppet M, Sariban E. Ferster A, et al. Blood. 1996 Sep 15;88(6):1960-4. Blood. 1996. PMID: 8822914 Clinical Trial.
Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years.
Najean Y, Rain JD. Najean Y, et al. Blood. 1997 Nov 1;90(9):3370-7. Blood. 1997. PMID: 9345019 Clinical Trial.
Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion.
Sterkers Y, Preudhomme C, Laï JL, Demory JL, Caulier MT, Wattel E, Bordessoule D, Bauters F, Fenaux P. Sterkers Y, et al. Blood. 1998 Jan 15;91(2):616-22. Blood. 1998. PMID: 9427717
Five years of experience with hydroxyurea in children and young adults with sickle cell disease.
Ferster A, Tahriri P, Vermylen C, Sturbois G, Corazza F, Fondu P, Devalck C, Dresse MF, Feremans W, Hunninck K, Toppet M, Philippet P, Van Geet C, Sariban E. Ferster A, et al. Blood. 2001 Jun 1;97(11):3628-32. doi: 10.1182/blood.v97.11.3628. Blood. 2001. PMID: 11369660